JP2022164646A - 乳幼児おむつ皮膚炎の症度の検出方法 - Google Patents

乳幼児おむつ皮膚炎の症度の検出方法 Download PDF

Info

Publication number
JP2022164646A
JP2022164646A JP2022067883A JP2022067883A JP2022164646A JP 2022164646 A JP2022164646 A JP 2022164646A JP 2022067883 A JP2022067883 A JP 2022067883A JP 2022067883 A JP2022067883 A JP 2022067883A JP 2022164646 A JP2022164646 A JP 2022164646A
Authority
JP
Japan
Prior art keywords
gene
diaper dermatitis
infant
severity
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022067883A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022164646A5 (https=
Inventor
真恵子 岩村
Maeko Iwamura
高良 井上
Takayoshi Inoue
哲矢 桑野
Tetsuya Kuwano
裕也 上原
Yuya Uehara
恭子 志摩
Kyoko Shima
優子 福田
Yuko Fukuda
倫子 高木
Rinko Takagi
早苗 相良
Sanae Sagara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of JP2022164646A publication Critical patent/JP2022164646A/ja
Publication of JP2022164646A5 publication Critical patent/JP2022164646A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2022067883A 2021-04-15 2022-04-15 乳幼児おむつ皮膚炎の症度の検出方法 Pending JP2022164646A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021069365 2021-04-15
JP2021069365 2021-04-15

Publications (2)

Publication Number Publication Date
JP2022164646A true JP2022164646A (ja) 2022-10-27
JP2022164646A5 JP2022164646A5 (https=) 2025-04-02

Family

ID=83640724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022067883A Pending JP2022164646A (ja) 2021-04-15 2022-04-15 乳幼児おむつ皮膚炎の症度の検出方法

Country Status (2)

Country Link
JP (1) JP2022164646A (https=)
WO (1) WO2022220298A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024111617A1 (ja) * 2022-11-24 2024-05-30 花王株式会社 皮膚表上脂質検体内部標準遺伝子

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170241989A1 (en) * 2014-03-31 2017-08-24 Laboratoires Expanscience Method for evaluating the harmful effects of urine on children's skin
WO2018008319A1 (ja) * 2016-07-08 2018-01-11 花王株式会社 核酸試料の調製方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170241989A1 (en) * 2014-03-31 2017-08-24 Laboratoires Expanscience Method for evaluating the harmful effects of urine on children's skin
WO2018008319A1 (ja) * 2016-07-08 2018-01-11 花王株式会社 核酸試料の調製方法

Also Published As

Publication number Publication date
WO2022220298A1 (ja) 2022-10-20

Similar Documents

Publication Publication Date Title
JP7849812B2 (ja) パーキンソン病の検出方法
JP7743217B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7762549B2 (ja) アトピー性皮膚炎の症度変化の検出方法
JP7743239B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP2022164646A (ja) 乳幼児おむつ皮膚炎の症度の検出方法
JP7743475B2 (ja) アトピー性皮膚炎の検出方法
JP7743289B2 (ja) アトピー性皮膚炎の症度の検出方法
JP2023002298A (ja) 糖尿病指標値の検出方法
JP7845827B2 (ja) 月経前症候群の重症度検出方法
JP2022164647A (ja) 乳幼児顔湿疹の症度の検出方法
JP7767500B2 (ja) アトピー性皮膚炎の重症度の検出方法
JP7750481B2 (ja) 内臓脂肪面積の検出方法
JP7743474B2 (ja) 乳幼児アトピー性皮膚炎の検出方法
JP7847451B2 (ja) アトピー性皮膚炎による皮膚痒みの症度悪化の検出方法
JP7847450B2 (ja) アトピー性皮膚炎の症度悪化の検出方法
JP2023073135A (ja) 更年期障害の重症度の検出方法
JP2023045067A (ja) 不眠の検出方法
JP2023073134A (ja) ホットフラッシュの検出方法
JP2024045047A (ja) 肥満改善剤の有効性予測方法
JP2023048810A (ja) 慢性ストレスレベルの検出方法
JP2023048811A (ja) 疲労の検出方法
JP2024045048A (ja) 肥満改善剤の有効性予測方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260127